RECURRENT OR METASTATIC SOLID TUMORS
Clinical trials for RECURRENT OR METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OR METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for RECURRENT OR METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: experimental drug targets multiple tumor types
Disease control Recruiting nowThis study is testing an experimental drug called ifinatamab deruxtecan (I-DXd) in people with advanced solid tumors that have returned or spread after standard treatments. It aims to see if the drug can shrink tumors and control the disease for various cancers, including endomet…
Matched conditions: RECURRENT OR METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New shot in the arm for advanced cancer patients
Disease control Recruiting nowThis early-stage trial is testing a new under-the-skin injection version of a cancer drug called trastuzumab deruxtecan. It aims to see if this method is safe, tolerable, and effective for adults whose solid tumors have spread or returned after treatment. The study will first fin…
Matched conditions: RECURRENT OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC